Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 5 studies | 21% ± 5% |
Insufficient scRNA-seq data for expression of GPR4 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 3109.61 | 457 / 459 | 98% | 10.03 | 1094 / 1118 |
thymus | 100% | 2823.03 | 653 / 653 | 96% | 15.50 | 578 / 605 |
lung | 100% | 3938.04 | 578 / 578 | 94% | 6.82 | 1090 / 1155 |
adrenal gland | 95% | 886.18 | 244 / 258 | 98% | 23.45 | 226 / 230 |
kidney | 100% | 1700.08 | 89 / 89 | 81% | 38.08 | 733 / 901 |
stomach | 83% | 596.11 | 299 / 359 | 96% | 8.80 | 275 / 286 |
uterus | 96% | 1024.20 | 164 / 170 | 81% | 5.15 | 373 / 459 |
prostate | 88% | 853.33 | 215 / 245 | 80% | 4.61 | 404 / 502 |
intestine | 74% | 566.19 | 716 / 966 | 93% | 7.30 | 491 / 527 |
esophagus | 70% | 569.88 | 1018 / 1445 | 96% | 9.45 | 176 / 183 |
bladder | 71% | 986.29 | 15 / 21 | 93% | 6.89 | 470 / 504 |
brain | 60% | 592.54 | 1592 / 2642 | 96% | 8.56 | 679 / 705 |
skin | 56% | 379.39 | 1021 / 1809 | 93% | 6.44 | 438 / 472 |
ovary | 60% | 416.42 | 108 / 180 | 83% | 3.93 | 355 / 430 |
pancreas | 39% | 184.30 | 128 / 328 | 99% | 11.48 | 176 / 178 |
liver | 28% | 173.26 | 64 / 226 | 93% | 5.77 | 379 / 406 |
adipose | 100% | 3988.87 | 1204 / 1204 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 3.14 | 1 / 1 |
heart | 99% | 1577.44 | 849 / 861 | 0% | 0 | 0 / 0 |
spleen | 90% | 570.05 | 217 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 89% | 5.07 | 40 / 45 |
blood vessel | 69% | 630.56 | 927 / 1335 | 0% | 0 | 0 / 0 |
muscle | 66% | 389.93 | 533 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 66% | 2.75 | 19 / 29 |
eye | 0% | 0 | 0 / 0 | 50% | 2.00 | 40 / 80 |
peripheral blood | 1% | 2.64 | 6 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0043114 | Biological process | regulation of vascular permeability |
GO_0060055 | Biological process | angiogenesis involved in wound healing |
GO_0072144 | Biological process | glomerular mesangial cell development |
GO_0050729 | Biological process | positive regulation of inflammatory response |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0035025 | Biological process | positive regulation of Rho protein signal transduction |
GO_0007200 | Biological process | phospholipase C-activating G protein-coupled receptor signaling pathway |
GO_0030155 | Biological process | regulation of cell adhesion |
GO_0010447 | Biological process | response to acidic pH |
GO_0007189 | Biological process | adenylate cyclase-activating G protein-coupled receptor signaling pathway |
GO_0016525 | Biological process | negative regulation of angiogenesis |
GO_0005886 | Cellular component | plasma membrane |
GO_0004930 | Molecular function | G protein-coupled receptor activity |
Gene name | GPR4 |
Protein name | G-protein coupled receptor 4 (G-protein coupled receptor 6C.l) (GPR6C.l) |
Synonyms | |
Description | FUNCTION: Proton-sensing G-protein coupled receptor couples to multiple intracellular signaling pathways, including GNAS/cAMP, GNAQ/phospholipase C (PLC), and GNA12/GNA13/Rho pathways . Acidosis-induced GPR4 activation increases paracellular gap formation and permeability of vascular endothelial cells through the GNA12/GNA13/Rho GTPase signaling pathway . In the brain may mediate central respiratory sensitivity to CO(2)H(+) (By similarity). . |
Accessions | P46093 ENST00000323040.5 |